Nuzenio

Wins Fda Nda

Wins Fda Nda news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

China accepts NDA for Alebund's phosphate binder AP301 after Phase III success - AllSciAllSci · Fri, 07 Aug 2026 16:31:47 GMTReckitt wins FDA approval for new Mucinex Cold & Flu OTC - Chain Drug ReviewChain Drug Review · Wed, 05 Aug 2026 15:45:23 GMTBridgeBio Pharma (BBIO) Wins FDA Review For Encaleret In ADH1 - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 01:11:00 GMTPolyPid's Double Win: D-PLEX₁₀₀ Gains NDA Acceptance and Priority Review, Ahead of Schedule (NASDAQ: PYPD - BenzingaBenzinga · Fri, 31 Jul 2026 15:28:54 GMTBridgeBio Pharma (BBIO) Wins FDA NDA Acceptance, Is The Upside Already Priced In? - SahmSahm · Thu, 30 Jul 2026 07:00:00 GMTPolyPid (Nasdaq: PYPD) gets FDA Priority Review and $15M milestone - Stock TitanStock Titan · Wed, 29 Jul 2026 12:35:40 GMT

Timeline

Fri, 07 Aug 2026 16:31:47 GMTChina accepts NDA for Alebund's phosphate binder AP301 after Phase III success - AllSci
Wed, 05 Aug 2026 15:45:23 GMTReckitt wins FDA approval for new Mucinex Cold & Flu OTC - Chain Drug Review
Tue, 04 Aug 2026 01:11:00 GMTBridgeBio Pharma (BBIO) Wins FDA Review For Encaleret In ADH1 - Yahoo Finance
Fri, 31 Jul 2026 15:28:54 GMTPolyPid's Double Win: D-PLEX₁₀₀ Gains NDA Acceptance and Priority Review, Ahead of Schedule (NASDAQ: PYPD - Benzinga
Thu, 30 Jul 2026 07:00:00 GMTBridgeBio Pharma (BBIO) Wins FDA NDA Acceptance, Is The Upside Already Priced In? - Sahm
Wed, 29 Jul 2026 12:35:40 GMTPolyPid (Nasdaq: PYPD) gets FDA Priority Review and $15M milestone - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Wins Fda Nda.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.